Home > Analytics > DR REDDYS LABORATORIES

DR REDDYS LABORATORIES
Intrinsic Value | Fundamental Analysis

BOM : 500124     NSE : DRREDDY    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Nov 28,2023
Price(EOD): ₹ 5,671.25
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 94,596.45 Cr
Value of ₹ 1 Lac invested in DR REDDYS LABORATORIES
on Nov 28,2018 (price: ₹ 2,570.40)

₹ 1 L

₹ 2.21 L

1W : 0.5% 1M : 5.3% 1Y : 28%
COMMUNITY POLL
for DR REDDYS LABORATORIES
Please provide your vote to see the results
DR REDDYS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
Industry Peers & Returns1W1M1Y
DR REDDYS LABORATORIES 0.5% 5.3% 28%
SUN PHARMACEUTICAL INDUSTRIES -0.9% 7.2% 17.6%
DIVIS LABORATORIES 1% 10.2% 14.1%
CIPLA -4.9% 1.6% 8.3%
TORRENT PHARMACEUTICALS -1.9% 8.2% 29.1%
ABBOTT INDIA -0.9% 4.7% 20.4%
ZYDUS LIFESCIENCES -1.4% 9.6% 62.4%
ALKEM LABORATORIES 1.4% 23.9% 45.8%
LUPIN 1.8% 10% 72.9%

FUNDAMENTAL ANALYSIS OF DR REDDYS LABORATORIES

 
Fundamentals Score
[ Q(TTM): Sep2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 DRREDDY is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF DR REDDYS LABORATORIES

 
Valuation Score
[As on : Nov 28,2023 ]

Ratio Consolidated
P/E
P/B
P/S
18.66
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 5,069.10 Cr
[Latest Qtr - Sep2023 - Consolidated Results ]

4.09
P/B Calculated based on Book Value of Rs 23,140.40 Cr
[Latest Year - Mar2023 - Consolidated Results ]

3.53
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 26,765.50 Cr
[Latest Qtr - Sep2023 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 12% undervalued companies ! Discover More →

FAIR VALUE OF DR REDDYS LABORATORIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
36%
11%
14%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF DR REDDYS LABORATORIES


Insights 💡 DRREDDY is one of the top 60% companies with bullish price momentum currently! Discover More →

DR REDDYS LABORATORIES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF DR REDDYS LABORATORIES

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.12
0.07
0.1
0.1
0.18
0.17
0.14
0.16
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF DR REDDYS LABORATORIES

Pledged Promoter Shares
0 %
As on : Sep2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF DR REDDYS LABORATORIES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
2.14%
-2.61%
3.62%
5.52%
9.01%
5.76%
19.56%
34.34%
QtrlyTrend
6
Latest Qtr: Sep2023
Quarterly Result Analysis →


DR REDDYS LABORATORIES related INDICES

BSE Indices1W1M1Y
S&P BSE 100 ESG INDEX 1.2% 5.8% 7.1%
S&P BSE 100 LARGECAP TMC 1.1% 6.1% 8.1%
S&P BSE LARGECAP 1% 6% 7.5%
S&P BSE LARGE MIDCAP 1% 6.7% 11.6%
S&P BSE 200 1% 6.7% 11.3%
NSE Indices1W1M1Y
NIFTY 100 EQUAL WEIGHT 1.5% 8.5% 16%
NIFTY50 EQUAL WEIGHT 1.4% 7.3% 18.3%
NIFTY GROWTH SECTOR 15 1.2% 11.6% 9.1%
NIFTY 200 1.1% 6.9% 11.8%
NIFTY 100 1.1% 6.2% 8.3%

You may also like the below Video Courses


FAQ about DR REDDYS LABORATORIES


Is DR REDDYS LABORATORIES good for long term investment?

As on Nov 28,2023, the Fundamentals of DR REDDYS LABORATORIES look Strong and hence it may be good for long term investment! See Financial Performance of DR REDDYS LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is DR REDDYS LABORATORIES UnderValued or OverValued?

As on Nov 28,2023, DR REDDYS LABORATORIES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of DR REDDYS LABORATORIES ?

As on Nov 28,2023, the Intrinsic Value of DR REDDYS LABORATORIES is Rs. 4,990.45 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 4,175.78
Fair Value [Median EV / Sales Model] : Rs. 5,113.79
Fair Value [Median Price / Sales Model] : Rs. 4,990.45
Estimated Median Fair Value of DR REDDYS LABORATORIES : Rs. 4,990.45

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is DR REDDYS LABORATORIES trading at a Premium or Discount?

As on Nov 28,2023, DR REDDYS LABORATORIES is trading at a Premium of 14% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].